Five Prime Therapeutics
They are a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics.
Last Closing Price
January 25, 2018
Goldman Sachs & Co., J.P. Morgan, Leerink Partners, Wells Fargo
To view the prospectus for Five Prime Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253